ILK and hepatocellular carcinoma: Preventive/therapeutic: CBD protects against PFOS-induced inflammation and fibrosis by modulating the PAD4–MET–CCDC25–ILK–NF-κB axis. Its antifibrotic and anti-inflammatory effects suggest potential to prevent HCC progression associated with chronic environmental contaminant exposure.